Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor. Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? The Zacks Style ...

Zacks Premium - Zacks Premium是公司最受欢迎的服务之一，提供每日更新的Zacks Rank和Zacks Industry Rank，全面访问Zacks 1 Rank List，股票研究报告和Premium股票筛选工具[2] Zacks Focus List - Zacks Focus List是一个由50只股票组成的投资组合，旨在帮助长期投资者建立个人投资组合，这些股票被认为将在未来12个月内表现优于市场[3] - Focus List中的股票每一次选择都伴随着完整的Zacks分析报告，解释为什么选择该股票以及为何认为它对长期投资有利[4] - Focus List的过去表现证明了投资者应该将其视为一个起点，2020年，Focus List的年化收益率为13.85%，而标普500指数的回报率为9.38%[5] - Focus List的累计回报率为2,519.23%，而标普500指数的回报率为854.95%，回报期间为1996年2月1日至2021年3月31日[6] Zacks Focus List选股方法 - Zacks Focus List的选股方法主要依赖于盈利预期修订的力量，分析师通过审查可能影响未来盈利的各个方面来确定盈利预期[7] - 盈利预期修订对股票价格有很大影响，Focus List中的股票很可能会获得盈利预期修订，这可能导致价格动量[13] HCA Healthcare - HCA Healthcare是Focus List中的一只股票，自2019年1月7日以123.39美元/股的价格被加入Focus List以来，股价已上涨158.88%至319.43美元/股，目前是Zacks Rank的2（买入）[16] - HCA Healthcare的盈利预期在过去60天内有三位分析师上调，2024财年的Zacks Consensus Estimate增加了0.21美元至20.58美元，分析师预计HCA的盈利将在当前财年增长8.3%[17]

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though? Let's take a look at what these Wall Street heavyweights have to say about HCA Healthcare (HCA) before we discuss the reliability of brokerage recommendations and how to use them to your advantage. HCA currently has an avera ...

Wall Street analysts forecast that HCA Healthcare (HCA) will report quarterly earnings of $5.01 per share in its upcoming release, pointing to a year-over-year increase of 1.6%. It is anticipated that revenues will amount to $16.84 billion, exhibiting an increase of 8% compared to the year-ago quarter. Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of ...

HCA Healthcare, Inc. (HCA) is set to beat on earnings for the first quarter of 2024, the results for which are scheduled to be released on Apr 26, before the opening bell. Continued growth in Medicare and Medicaid businesses is expected to aid its results along with several other factors discussed below. This will likely have a positive impact on its price performance, which is already up handsomely in 2024. Price Performance Over the year-to-date period, HCA Healthcare shares have gained 14.7%, comfortably ...

In the latest market close, HCA Healthcare (HCA) reached $310.31, with a +1.7% movement compared to the previous day. The stock's performance was ahead of the S&P 500's daily gain of 0.87%. On the other hand, the Dow registered a gain of 0.67%, and the technology-centric Nasdaq increased by 1.11%. Prior to today's trading, shares of the hospital operator had lost 7.53% over the past month. This has lagged the Medical sector's loss of 6.67% and the S&P 500's loss of 3.97% in that time. The upcoming earnings ...

HCA Healthcare (HCA) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price. The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on April 26 ...

股价表现 - HCA Healthcare (HCA) 最新收盘价为 $311.03，较前一天下跌了 -0.91% [1] - HCA Healthcare 过去一个月股价下跌了 5.02%，优于医疗行业的 6.07% 下跌，但落后于标普500指数的 1.09% 下跌 [2] 财务预期 - HCA Healthcare 即将发布财报，预计每股收益为 $5.01，同比增长 1.62%，营收预期为 $16.84 亿美元，同比增长 8.04% [3] - Zacks Consensus Estimates 预测 HCA Healthcare 整个财年每股收益为 $20.58，营收为 $69.03 亿美元，同比分别增长 8.26% 和 6.25% [4] 分析师评级 - 分析师对 HCA Healthcare 的最新预测变化可能反映了近期业务趋势的变化，向上修订的预测表明分析师对公司业务运营和盈利能力持乐观态度 [5] - Zacks Rank 模型结合这些预测变化，提供了一个实用的评级系统，HCA Healthcare 目前的评级为 2 (买入) [6] 行业比较 - HCA Healthcare 目前的前瞻市盈率为 15.25，低于行业的 15.43 [7] - HCA 的 PEG 比率为 1.51，考虑到公司的预期盈利增长，医疗 - 医院行业的平均 PEG 比率为 1.81 [8] 行业排名 - 医疗 - 医院行业属于医疗部门，该行业的 Zacks Industry Rank 为 98，在所有 250+ 个行业中排名前 39% [9] - Zacks Industry Rank 通过计算各个行业组内个股的平均 Zacks Rank 来评估各行业组的实力，研究显示排名前 50% 的行业表现优于后 50% 的行业 [10] 决策建议 - 利用 Zacks.com 及时了解这些股票变动指标，以及其他信息，以便在下一个交易日做出相应决策 [11]

HCA Healthcare - HCA Healthcare 是医疗行业中的一家公司，目前在 Zacks Sector Rank 中排名第4位[2] - HCA Healthcare 目前的 Zacks Rank 为 2 (Buy)，可能在未来一到三个月内表现优于整个市场[3] - HCA Healthcare 今年迄今为止的回报率为19.2%，远高于医疗股票的平均回报率0.2%[5] 医疗行业表现 - HCA Healthcare 属于医疗-医院行业，该行业今年迄今为止的平均回报率为16.4%，在行业内表现较好[8] - Addus HomeCare (ADUS) 是另一家医疗股票，今年迄今为止的回报率为4.2%，也表现优异[6] - Addus HomeCare 属于医疗-门诊和家庭保健行业，该行业今年迄今为止的回报率为+2.9%[9]

Zacks Premium - Zacks Premium提供多种方式帮助投资者更加聪明和自信[2] - Zacks Style Scores是与Zacks Rank一起开发的互补指标，根据价值、增长和动量特征对股票进行评级[3] - VGM Score是所有Style Scores的组合，是最全面的指标之一，帮助筛选具有最具吸引力价值、最佳增长预测和最有前景动量的公司[8] Zacks Rank - Zacks Rank利用盈利预期修订来构建一个成功的投资组合[9] - 拥有Zacks Rank 1或2以及Style Scores A或B的股票具有最高成功概率[12] - 股票的盈利预期修订方向是选择购买股票时的关键因素[13] HCA Healthcare - HCA Healthcare是一个值得关注的股票，拥有Zacks Rank 2和VGM Score A[15] - HCA Healthcare的盈利预期在过去60天内有两位分析师上调，Zacks Consensus Estimate也有所增加[17]